BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31737186)

  • 21. Long noncoding RNA LINC00460 targets miR-539/MMP-9 to promote meningioma progression and metastasis.
    Xing H; Wang S; Li Q; Ma Y; Sun P
    Biomed Pharmacother; 2018 Sep; 105():677-682. PubMed ID: 29906745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis.
    Zhang C; Xu L; Li X; Chen Y; Shi T; Wang Q
    Technol Cancer Res Treat; 2023; 22():15330338231164359. PubMed ID: 36938678
    [No Abstract]   [Full Text] [Related]  

  • 23. The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma.
    Wen L; Zhang X; Bian J; Han L; Huang H; He M; Wei M; Wang P
    Oncol Lett; 2019 Apr; 17(4):3874-3880. PubMed ID: 30881506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Noncoding RNA LINC00460 Modulates MMP-9 to Promote Cell Proliferation, Invasion and Apoptosis by Targeting miR-539 in Papillary Thyroid Cancer.
    Zou X; Guo ZH; Li Q; Wang PS
    Cancer Manag Res; 2020; 12():199-207. PubMed ID: 32021436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINC00460 modulates KDM2A to promote cell proliferation and migration by targeting miR-342-3p in gastric cancer.
    Wang F; Liang S; Liu X; Han L; Wang J; Du Q
    Onco Targets Ther; 2018; 11():6383-6394. PubMed ID: 30323616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA ANRIL promotes tumorgenesis through regulation of FGFR1 expression by sponging miR-125a-3p in head and neck squamous cell carcinoma.
    Zhang LM; Ju HY; Wu YT; Guo W; Mao L; Ma HL; Xia WY; Hu JZ; Ren GX
    Am J Cancer Res; 2018; 8(11):2296-2310. PubMed ID: 30555745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA LINC00460 facilitates the proliferation and metastasis of renal cell carcinoma via PI3K/AKT signaling pathway.
    Zhou FJ; Meng S; Wu XF; Hou PF; Li ML; Chu SF; Bai J; Zheng JN
    J Cancer; 2022; 13(9):2844-2854. PubMed ID: 35912013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LINC00460 Hypomethylation Promotes Metastasis in Colorectal Carcinoma.
    Zhang H; Lu Y; Wu J; Feng J
    Front Genet; 2019; 10():880. PubMed ID: 31632435
    [No Abstract]   [Full Text] [Related]  

  • 30. LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer.
    Meng X; Sun W; Yu J; Zhou Y; Gu Y; Han J; Zhou L; Jiang X; Wang C
    Mol Ther Nucleic Acids; 2020 Dec; 22():1004-1015. PubMed ID: 33251049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
    Zhao H; Wang Y; Ren X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31123168
    [No Abstract]   [Full Text] [Related]  

  • 32. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
    Zhang S; Xu J; Wang H; Guo H
    Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 checkpoint.
    Yao J; Gao R; Luo M; Li D; Guo L; Yu Z; Xiong F; Wei C; Wu B; Xu Z; Zhang D; Wang J; Wang L
    Cancer Cell Int; 2022 Dec; 22(1):390. PubMed ID: 36482354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer.
    Lian Y; Yan C; Xu H; Yang J; Yu Y; Zhou J; Shi Y; Ren J; Ji G; Wang K
    Mol Ther Nucleic Acids; 2018 Sep; 12():684-697. PubMed ID: 30092404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberration of lncRNA LINC00460 is a Promising Prognosis Factor and Associated with Progression of Clear Cell Renal Cell Carcinoma.
    Zhang S; Zhang F; Niu Y; Yu S
    Cancer Manag Res; 2021; 13():6489-6497. PubMed ID: 34429655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.
    Zhao G; Fu Y; Su Z; Wu R
    Cell Physiol Biochem; 2018; 50(1):332-341. PubMed ID: 30282065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
    Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
    Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.